Pharmaceutical Excipients: Part 3 – Integration of Excipients into the Design or Experiments for Pharmaceutical Product Design Space Development
Posted on October 6, 2014
By: Chris Moreton, Partner
FinnBrit Consulting
Summary Rational selection of excipients and their incorporation into formulation development programmes undertaken using QbD can be daunting. Incorporation of excipient variability into the DoE will be necessary. QbD does not require the manufacture of excipients at the extremes of specification. M...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















